Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tunodafil - Yangtze River Pharmaceutical Group

Next Previous
X
Search
Drug Profile

Tunodafil - Yangtze River Pharmaceutical Group

Alternative Names: Ecocarbamate hydrochloride; Gluconocin hydrochloride; Yonkenafil hydrochloride

Latest Information Update: 12 Aug 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Tasly Pharmaceutical Group; Yangtze River Pharmaceutical Group
  • Developer Yangtze River Pharmaceutical Group
  • Class Erectile dysfunction therapies; Piperazines; Pyrimidinones; Pyrroles; Small molecules; Sulfones
  • Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Erectile dysfunction

Most Recent Events

  • 01 Jul 2017 Phase-I clinical trials in Erectile dysfunction (In volunteers) in China (PO) (ChiCTR-OIC17011807)
  • 01 Jul 2017 Yangtze River Pharmaceutical Group and Chinese PLA General Hospital plans a phase I trial for Erectile dysfunction (In volunteers) in China (ChiCTR-IIR17011814)
  • 26 Jun 2017 Chinese PLA General Hospital and Yangtze River Pharmaceutical Group initiates enrolment in a phase I trial in Erectile dysfunction (In volunteers) in China (ChiCTR-IIC17011805)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top